<DOC>
	<DOCNO>NCT01139047</DOCNO>
	<brief_summary>The purpose study compare tolerability MetroGel® 1 % Finacea® 15 % subject healthy skin apply accord product labeling three week .</brief_summary>
	<brief_title>Split-face Tolerability Comparison Between MetroGel® 1 % v Finacea® 15 % Subjects With Healthy Skin</brief_title>
	<detailed_description />
	<mesh_term>Skin Manifestations</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Healthy male female adult ( age 18 year old ) Subjects healthy skin determine clinical grader Subjects degree skin pigmentation interfere read skin reaction Subjects know allergy one component study drug ( refer package insert MetroGel® 1 % Finacea® Gel 15 % ) Subjects participate another investigational drug device research study within 30 day enrollment Subjects washout period topical treatment treat area le 1 week corticosteroid and/or 4 week retinoids Subjects washout period systemic treatment le 1 week medication may increase photosensitivity and/or 4 week corticosteroid and/or 6 month retinoids Subjects current sunburn , eczema , atopic dermatitis , perioral dermatitis , rosacea , topical condition area treat Subjects foresee unprotected intense UV exposure study ( mountain sport , UV radiation , sunbathe , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>